Anthony J. Magdalinski, DO
Medical Oncology in Chalfont, PA
About Dr. Anthony Magdalinski
Dr. Anthony Magdalinski is a physician specializing in medical oncology practicing in Chalfont, PA, a graduate of Philadelphia College of Osteopathic Medicine (1985). Records list 2 practice addresses. Affiliated with Doylestown Hospital, Hospital of Univ of Pennsylvania, St Luke's Hospital - Grand View Campus and 2 more. Treated 758 Medicare patients in 2024.
| Specialty | Medical OncologyOther medical oncology doctors in Chalfont |
|---|---|
| Credentials | DO |
| Education | Philadelphia College of Osteopathic Medicine, 1985CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1528067352National Provider Identifier (CMS NPPES), issued July 2005 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
| Telehealth | Offers telehealth servicesCMS Doctors and Clinicians |
Where Dr. Anthony Magdalinski practices
- Alliance Cancer Specialists P.c. 700 Horizon Dr, Suite 106, Chalfont, PA 18914 (215) 997-1134 · Directions · group of 43 clinicians
- Alliance Cancer Specialists, P.c. 915 Lawn Ave, Suite 202, Sellersville, PA 18960 (215) 453-3300 · Directions · group of 43 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Anthony Magdalinski's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Hematology & Oncology Primary | PA 0500600FL |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Hospital affiliations of Dr. Anthony Magdalinski
- Doylestown HospitalHospital · Doylestown, PA
- Hospital of Univ of PennsylvaniaHospital · Philadelphia, PA
- St Luke's Hospital - Grand View CampusHospital · Sellersville, PA
- St Luke's Hospital - Upper Bucks CampusHospital · Quakertown, PA
- St Luke's Hospital BethlehemHospital · Bethlehem, PA
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Anthony Magdalinski's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,044 | $7.52 |
| Insertion of needle into vein for collection of blood sample | 992 | $8.64 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 632 | $135.85 |
| Injection of additional new drug or substance into vein | 495 | $16.40 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 458 | $96.59 |
| Injection of drug or substance under skin or into muscle | 357 | $14.74 |
| Administration of chemotherapy into vein, 1 hour or less | 285 | $138.31 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 222 | $76.98 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Anthony Magdalinski's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as subgroup. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Anthony Magdalinski (2025)
$583.57 in 24 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 23 | $566.35 |
| Education | 1 | $17.22 |
Paying companies: AbbVie Inc. ($161.53), AstraZeneca Pharmaceuticals LP ($86.60), Janssen Biotech, Inc. ($77.86), ARRAY BIOPHARMA INC ($74.70), Celgene Corporation ($27.43), Legend Biotech USA Inc. ($26.69).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Anthony Magdalinski
What kind of clinician is Dr. Anthony Magdalinski?
Dr. Anthony Magdalinski is listed as a physician specializing in medical oncology.
Where does Dr. Anthony Magdalinski practice?
Alliance Cancer Specialists P.c. at 700 Horizon Dr, Suite 106, Chalfont, PA 18914, and 1 other address in the records.
What is the office phone number for Dr. Anthony Magdalinski?
The listed office number is (215) 997-1134. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Anthony Magdalinski?
The National Provider Identifier is 1528067352.
Does Dr. Anthony Magdalinski accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Anthony Magdalinski affiliated with?
Doylestown Hospital, Hospital of Univ of Pennsylvania, St Luke's Hospital - Grand View Campus, St Luke's Hospital - Upper Bucks Campus, St Luke's Hospital Bethlehem.
Where did Dr. Anthony Magdalinski go to medical school?
Philadelphia College of Osteopathic Medicine, graduating in 1985.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2014-09-16 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.